0000000000213276

AUTHOR

W. Jäger

showing 16 related works from this author

UP-01.160 Long-Term Follow-Up Is Necessary for Patients Presenting With pT1 and pT2 Renal Cell Carcinoma

2011

medicine.medical_specialtyLong term follow upbusiness.industryRenal cell carcinomaUrologymedicinebusinessmedicine.diseaseSurgeryUrology
researchProduct

Oncologic Long-term Outcome of Elective Nephron-sparing Surgery Versus Radical Nephrectomy in Patients With Renal Cell Carcinoma Stage pT1b or Greate…

2011

Objectives To analyze the oncologic outcome and overall survival (OS) for patients with renal cell carcinoma (RCC) >4 cm undergoing radical nephrectomy (RN) or elective nephron-sparing surgery (NSS) in a matched-pair cohort. Methods From 1988 to 2007, we identified 829 patients in our clinic treated with either RN (n = 641) or open NSS (n = 188) for renal masses >4 cm. After matching the cohort for age, time of surgery, grade, TNM stage, tumor size, and sex and excluding patients with metastases, benign lesions with an imperative indication, and those with missing records, 173 remained for oncologic analysis. OS, cancer-specific survival, and progression-free survival were estimated using t…

AdultMalemedicine.medical_specialtyMatched-Pair AnalysisUrologymedicine.medical_treatmentNephrectomyRenal cell carcinomaHumansMedicineIn patientStage (cooking)Carcinoma Renal CellAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelHazard ratioMiddle Agedmedicine.diseaseKidney NeoplasmsConfidence intervalNephrectomySurgeryTreatment OutcomeElective Surgical ProceduresCohortDisease ProgressionFemalebusinessUrology
researchProduct

Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer.

2019

To compare toxicity and response of docetaxel chemotherapy between metastatic hormone-sensitive prostate cancer (mHSPC) and castration-resistant metastatic prostate cancer (mCRPC) patients of the same therapeutic era for assessing of upfront docetaxel against the benchmark of docetaxel in the castrate resistant stage in the setting outside of clinical trials.A prospectively collected database of real-world prostate cancer patients receiving docetaxel was divided in mHSPC and mCRPC cases and retrospectively analyzed. Principal objectives were toxicity measured by the common criteria of adverse events terminology and response characterized by Prostate specific antigen decline and radiographic…

OncologyMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsUrologymedicine.medical_treatment030232 urology & nephrologyAntineoplastic AgentsDocetaxelSeverity of Illness Index03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineHumansProspective StudiesStage (cooking)Adverse effectAgedNeoplasm StagingRetrospective StudiesChemotherapyPerformance statusbusiness.industryProstateMiddle AgedProstate-Specific Antigenmedicine.diseasePrognosisProgression-Free SurvivalClinical trialRadiographyProstate-specific antigenProstatic Neoplasms Castration-ResistantOncologyDocetaxelClinical Trials Phase III as Topic030220 oncology & carcinogenesisDisease ProgressionKallikreinsbusinessmedicine.drugUrologic oncology
researchProduct

Surgery Illustrated - Surgical Atlas

2010

CystectomyMedical illustrationmedicine.medical_specialtymedicine.anatomical_structureUrinary bladderAtlas (anatomy)business.industryUrologyGeneral surgerymedicine.medical_treatmentmedicinebusinessBJU International
researchProduct

Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal…

2010

Objective To analyse renal function, perioperative morbidity and overall survival (OS) in patients aged 65 years treated by radical nephrectomy (RN) or elective nephron-sparing surgery (NSS) for renal tumours > 4 cm. Patients and methods From our database, we identified 829 patients with renal tumours > 4 cm treated by either RN (n = 641) or NSS (n= 188) at our institution between 1981 and 2007. After excluding patients with imperative indication and metastases, we identified retrospectively 81 patients aged 65 years (elderly patients) treated for renal tumours > 4 cm. In all, 36 and 33 patients underwent NSS and 45 and 52 patients underwent RN in the young and elderly group, respectively. …

medicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentRenal functionPerioperativeurologic and male genital diseasesmedicine.diseaseNephrectomySurgerymedicineOverall survivalCarcinomaNephron sparing surgeryYoung adultbusinessKidney diseaseBJU International
researchProduct

Orthotopic MAINZ pouch bladder substitution – long-term follow-up

2021

Introduction After radical cystectomy, orthotopic neobladder is one surgical strategy for urinary diversion. To assess the usefulness of an operation, long-term data are essential. We examined long-term complications and continence rates of orthotopic ileocecal (MAINZ pouch) bladder substitution. Material and methods Between 1986 and 2011, 193 patients underwent orthotopic MAINZ pouch bladder substitution. Until July 2000, ureter implantation was performed into the ascending colon through a submucosal tunnel technique (Goodwin-Hohenfellner). After July 2000, ureters were implanted into the terminal Ileum using the ileocecal valve to prevent reflux: the left spatulated ureter by an end-to-en…

Original PaperStress incontinencemedicine.medical_specialtyBladder cancerbusiness.industrymedicine.medical_treatmentUrinary diversionGeneral Medicineorthotopic bladder substitutionlong-term resultsmedicine.diseaseSurgeryCystectomyIleocecal valvemedicine.anatomical_structureUreterurinary diversionbladder cancerMedicineAscending colonPouchbusinessCentral European Journal of Urology
researchProduct

Robotic surgery can be safely performed for patients and healthcare workers during COVID‐19 pandemic

2021

OBJECTIVES: To investigate the safety of robotic surgery during COVID-19 pandemic concerning new-acquired COVID-19 infections for patients and healthcare workers. PATIENTS: We performed a retrospective single-centre cohort study of patients undergoing robotic surgery in initial period of COVID-19 pandemic. Patients and Healthcare workers COVID-19 infection status was assessed by structured telephone follow-up and/or repeated nasopharyngeal swabs. RESULTS: After 61 robotic surgeries (93,5% cancer surgery), 1 patient (1.6%) had COVID-19 infection. 60 healthcare workers cumulatively exposed to 1,187 hours of robotic surgery had no infection. One patient with postoperative proof of SARS-CoV-2 h…

Malesafetymedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Health Personnel610 MedizincoronavirusBiophysicsSARS‐CoV‐203 medical and health sciences0302 clinical medicineRobotic Surgical Procedures610 Medical sciencesHealth carePandemicmedicineHumansRobotic surgery030212 general & internal medicineElective surgeryPandemicsAgedRetrospective StudiesroboticsSARS-CoV-2business.industryCOVID-19Robotic Surgical ProceduresRetrospective cohort studyMiddle AgedinfectionComputer Science Applicationsbody regions030220 oncology & carcinogenesisEmergency medicineFemaleOriginal ArticleSurgerybusiness2019‐nCoVCohort studyThe International Journal of Medical Robotics and Computer Assisted Surgery
researchProduct

UP-01.200 Oncological Long-Term Results of Elective Nephron-Sparing Surgery versus Radical Nephrectomy for Renal Tumours Larger Than 4cm

2011

medicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentUrologymedicineLong term resultsNephron sparing surgerybusinessNephrectomySurgeryUrology
researchProduct

256 Functional analysis of elective nephron-sparing surgery versus radical nephrectomy for renal tumors larger than 4 cm

2012

Objective To preserve renal function, nephron sparing surgery (NSS) for renal tumors should be performed. Little is known about perioperative morbidity and long-term functional outcome of patients after elective NSS compared with radical nephrectomy (RN) in renal tumors >4 cm. Materials and Methods Eight-hundred twenty-nine patients were treated with either RN (n = 641) or NSS (n = 188) for renal tumors >4 cm. After pairing the cohort for age, grading, TNM, size, gender, and preoperative renal function and excluding patients with imperative indication and metastases, 247 patients remained for functional analysis. Serum creatinine (SCr) values were used to estimate glomerular filtration rate…

Creatininemedicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentUrologyRenal functionPerioperativeurologic and male genital diseasesmedicine.diseaseNephrectomySurgerychemistry.chemical_compoundchemistryCohortmedicineComplicationbusinessGrading (tumors)Kidney diseaseEuropean Urology Supplements
researchProduct

The timing of initial imaging in testicular cancer: impact on radiological findings and clinical decision making

2021

Background In testicular cancer determination of clinical stage and recommendation of therapeutic strategy after inguinal orchiectomy are based on primary imaging by CT-scan of the chest and CT- or MRI- abdomen. It has not been investigated so far, whether the imaging should be performed before or after primary testicular surgery. Staging before surgery means exposing all patients to CT radiation irrespective of ensured histologic malignancy while postoperative staging could pose a risk in biased clinical decision making by increased presence of unspecific lymph node enlargement caused by postsurgical effects. Therefore, we aimed to investigate the association between the timing of initial …

2748 UrologyMalemedicine.medical_specialtyUrologymedicine.medical_treatmentClinical Decision-Making610 Medicine & health2700 General MedicineMalignancyTesticular NeoplasmsmedicineHumansStage (cooking)Lymph nodeTesticular cancerNeoplasm StagingRetrospective StudiesInguinal orchiectomy2727 Nephrology10042 Clinic for Diagnostic and Interventional Radiologybusiness.industrymedicine.diseasemedicine.anatomical_structureNephrologyLymphatic MetastasisRadiological weaponCohortAbdomenRadiologybusinessMinerva Urology and Nephrology
researchProduct

Orthotopic Mouse Models of Urothelial Cancer

2017

Orthotopic mouse models of urothelial cancer are essential for testing novel therapies and molecular manipulations of cell lines in vivo. These models are either established by orthotopic inoculation of human (xenograft models) or murine tumor cells (syngeneic models) in immunocompromised or immune competent mice. Current techniques rely on inoculation by intravesical instillation or direct injection into the bladder wall. Alternative models include the induction of murine bladder tumors by chemical carcinogens (BBN) or genetic engineering (GEM).

0301 basic medicinebusiness.industry03 medical and health sciences030104 developmental biology0302 clinical medicineImmune systemMurine tumorCell cultureIn vivo030220 oncology & carcinogenesisChemical carcinogensIntravesical instillationCancer researchMedicineUrothelial cancerbusiness
researchProduct

SARS-CoV-2 outbreak in medical employees in a large urologic department: Spread, containment and outcome.

2021

Background The SARS-CoV-2 pandemic presents an unprecedented challenge to health care systems worldwide. Data on SARS-CoV-2 transmission in a hospital is rare and outbreaks among health care professionals are complex to control. Material and Methods Over the course of 6 consecutive weeks we recorded data on an exponential outbreak of SARS-CoV-2 within our department. We reconstructed the assumed route of the spread of infection, and the employees’ acute and late symptoms. Increasing preventive measures (mandatory face masks, intense training in hygiene, physical distancing whenever possible, and termination of visits from outside the hospital) were implemented. Results Within 6 weeks, 13 em…

medicine.medical_specialtyEpidemiologymedia_common.quotation_subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health PersonnelDisease Outbreaks03 medical and health sciences0302 clinical medicineHygienePandemicHealth careMajor ArticleMedicineHumans030212 general & internal medicinePandemicsmedia_common0303 health sciencesViral spreadPandemic030306 microbiologybusiness.industryTransmission (medicine)Medical settingSARS-CoV-2Health PolicyPublic Health Environmental and Occupational HealthOutbreakCOVID-19Face masksInfectious DiseasesEmergency medicinebusinessAmerican journal of infection control
researchProduct

Intermittent hyperammonemic encephalopathy after ureterosigmoidostomy: spontaneous onset in the absence of hepatic failure

2015

Intermittent hyperammonemic encephalopathy after ureterosigmoidostomy is a rare, but if unrecognized, potentially lethal condition. Ureterosigmoidostomy was performed in a male patient with bladder extrophy. After 35 years, he developed hyperammonemic encephalopathy. Diagnostic procedures did not reveal hepatic nor metabolic disorders. Despite administration of preventive medical treatment, several episodes recurred. A durable prevention was finally achieved by conversion into an ileal conduit. Intermittent hyperammonemic encephalopathy can occur decades after ureterosigmoidostomy. In the case of absence of metabolic disorders and resistance to medical treatment, conversion into a urinary d…

medicine.medical_specialtyPediatricshyperammonemic encephalopathyMedical treatmentcomplicationsbusiness.industrymedicine.medical_treatmentUrinary diversionBladder extrophyCase ReportGeneral MedicineGastroenterologybladder extrophyUreterosigmoidostomyIleal segmentMale patientInternal medicineurinary diversionMedicineHyperammonemic encephalopathybusinessureterosigmoidostomyCentral European Journal of Urology
researchProduct

Incidence, Risk Factors and Management of Symptomatic Lymphoceles after Radical Retropubic Prostatectomy

2017

Abstract Introduction We investigated the incidence, clinical course and risk factors for symptomatic lymphoceles after radical retropubic prostatectomy with pelvic lymph node dissection. Moreover, we explored parameters for the failure of percutaneous lymphocele drainage. Methods The incidence of symptomatic lymphoceles in patients with prostate cancer who underwent radical retropubic prostatectomy with pelvic lymph node dissection in our department between 2008 and 2013 was investigated retrospectively. The occurrence of lymphoceles was correlated with several clinical and histopathological parameters. In addition, logistic regression analysis was performed to assess the value of independ…

medicine.medical_specialtyPercutaneousbusiness.industryProstatectomyUrologymedicine.medical_treatment030232 urology & nephrologymedicine.diseaseSurgery03 medical and health sciencesDissectionLymphocele0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesismedicineLymphRisk factorbusinessLymph nodeRadical retropubic prostatectomyUrology Practice
researchProduct

Incidence, Clinical Symptoms and Management of Rectourethral Fistulas After Radical Prostatectomy

2009

Rectourethral fistula is a rare but severe complication after radical prostatectomy and there is no standardized treatment. We retrospectively evaluated the incidence, symptoms and management of rectourethral fistulas based on our experience.From 1999 to 2008 we performed 2,447 radical prostatectomies. Patients in whom postoperative rectourethral fistulas developed were identified. Based on the therapeutic approach patients were categorized into group 1-conservative treatment, group 2-colostomy with or without surgical closure and group 3-immediate surgical closure without colostomy.Rectourethral fistulas developed in 13 of 2,447 patients (0.53%) after radical prostatectomy. The risk of rec…

MaleNephrologymedicine.medical_specialtyUrinary FistulaUrologymedicine.medical_treatmentFistulaUrologyRectourethral fistulaInternal medicineUrethral DiseasesEpidemiologymedicineHumansRectal FistulaAgedRetrospective StudiesProstatectomyProstatectomybusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyMiddle Agedmedicine.diseaseSurgerybusinessRetropubic prostatectomyJournal of Urology
researchProduct

Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

1991

Cancer Researchmedicine.medical_specialtyOncologybusiness.industrymedicineGeneral MedicineDrug resistancePharmacologyIntensive care medicinebusinessJournal of Cancer Research and Clinical Oncology
researchProduct